Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm

Publisher： Karger

E-ISSN： 1664-5553|6|3|185-188

ISSN： 2235-1795

Source： Liver Cancer, Vol.6, Iss.3, 2017-03, pp. : 185-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications

By  

Liver Cancer, Vol. 6, Iss. 3, 2017-03 ,pp. : 204-215

Karger

Access to resources Recommend Favorite

Systemic Treatment of Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 19, Iss. 4, 2002-03 ,pp. : 311-323

Karger

Access to resources Recommend Favorite

Treatment of Hepatocellular Carcinoma

By  

Digestion, Vol. 59, Iss. 5, 1998-08 ,pp. : 556-562

Karger

Access to resources Recommend Favorite

Treatment of Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 32, Iss. 5, 2014-07 ,pp. : 554-563

Karger

Access to resources Recommend Favorite

Treatment of Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 34, Iss. 5, 2016-06 ,pp. : 597-602

Karger

Access to resources Recommend Favorite